A cost–benefit analysis of BCG revaccination in the Czech Republic

• 9 April 1999
• journal article
• Published by Elsevier in Vaccine
• Vol. 17  (15-16) , 1926-1935
• https://doi.org/10.1016/s0264-410x(98)00462-9

Abstract

Keywords

• COST–BENEFIT ANALYSIS
• TUBERCULOSIS
• BCG
• REVACCINATION